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Converting an odds ratio to a range of plausible relative
risks for better communication of research findings
Odds ratios are a necessary evil in medical research; although used as a measure of effect size
from logistic regressions and case-control studies, they are poorly understood.This paper provides
practical advice for authors and readers on converting odds ratios to relative risks
Robert L Grant senior lecturer in health and social care statistics
St George’s, University of London and Kingston University, London SW17 0RE, UK
The odds ratio is a common measure in medical research of the
effect size comparing two groups (treatments or risk factors) in
terms of an outcome that is either present or absent. However,
the odds ratio is poorly understood.1-3 The relative risk (also
called the risk ratio) is more intuitive, but cannot be obtained
from case-control studies or (except in rare instances) logistic
regressions. Because the misunderstanding arises from the odds
itself, simply describing it as a proportional change (for example,
explaining an odds ratio of 0.8 as “treatment X was associated
with a 20% reduction in the odds of the outcome”) is not helpful
for most people. This is a problemwhen communicating results
to healthcare professionals and policy makers, discussing
treatment options with patients, or seeking to conduct a
meta-analysis of studies reporting effect sizes in a mixture of
odds ratios and relative risks.
Unfortunately, confusion about odds is not the only problem;
there is also a danger of inaccuracy when communicating odds
ratios.When the outcome is rare, the odds ratio and relative risk
are about the same. Medical papers sometimes rely too heavily
on this approximation, discussing odds ratios in terms of risks.
Not only is the odds ratio a poor approximation for outcomes
which are not “rare” in the study, a statistical analysis with a
single odds ratio, common to all participants, does not imply a
single common relative risk. In fact, the relative risk depends
also on the risk of the outcome in the baseline or control group.
For brevity, I will refer to this as the baseline risk. Because of
this, the same odds ratio could imply a very different relative
risk for subgroups of the population with different baseline risks.
The formula for converting an odds ratio to a relative risk is
straightforward4 5 (fig⇓, table 1⇓):
Relative risk=odds ratio/(1−p0+(p0×odds ratio))
(Where p0 is the baseline risk.)
The odds ratio is always further away from 1 than the relative
risk, but they are more similar when the baseline risk is small,
as seen by the near diagonal line in the figure for 0.1 baseline
risk. Although the basic conversion is well understood, more
complex analyses may not have a simple “baseline risk.” For
example, the box describes the difference between odds and
risks using the example of a clinical trial of a smoking cessation
strategy.6 Odds ratios are used to summarise the effect of the
strategy on various dichotomous outcomes, and these are also
adjusted for ward discharge rates. This means that the baseline
risk (in the usual care group) will differ between wards,
according to the definition of a confounding factor.7 Therefore,
a single odds ratio can imply a range of relative risks, depending
on age.
Advice for authors of medical research
Authors of medical research should consider converting odds
ratios to relative risks in this way, and should provide the
observed risks if possible, because best practice in
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Box: Definitions of odds and risks
Definitions
• Outcome present for treatment: a
• Outcome present for control: b
• Outcome absent for treatment: c
• Outcome absent for control: d
• Total for treatment: a+c
• Total for control: c+d
Therefore:
• Odds of the outcome in the treatment group: a/c
• Odds of the outcome in the control group: b/d
• Odds can range from 0 to infinity but are always positive
• Odds ratio for the outcome comparing treatment with control: (a/c)/(b/d)=(a×d)/(b×c)
• In case-control studies, the odds ratio for having received the treatment, comparing outcome present to outcome absent, is also
(a×d)/(b×c), hence the use of odds ratios in this study design
• Risk of the outcome in the treatment group: a/(a+c)
• Risk of the outcome in the control group: b/(b+d)
• Risks can range from 0 to 1
• Relative risk comparing treatment with control: (a×(b+d))/(b×(a+c))
• For both the odds ratio and relative risk, 1 represents no difference between the groups
• The risk (and the odds) does not have to refer to an undesirable outcome
An applied example
A cluster randomised controlled trial by Murray and colleagues is used here to show these calculations.6 This study compared systematic
identification and support to quit smoking with discretionary support (usual care) in a hospital setting. Applying the above definitions:
• Number of participants who quit at four weeks after the hospital based intervention (“a”): 98
• Number of participants who did not quit at four weeks after the hospital based intervention (“b”): 162
• Number of participants who quit at four weeks after usual care (“c”): 37
• Number of participants who did not quit at four weeks after usual care (“d”): 187
• Total for the hospital based intervention (“a+c”): 260 participants
• Total for usual care (“c+d”): 224 participants
In this example, the odds ratio was 3.06 and the relative risk was 2.28, which means that patients’ “risk” of successfully quitting smoking
after four weeks in the intervention group was 2.28 times higher than in the usual care group. The baseline risk was 37/224=17%.
These figures are the crude odds ratio and relative risk, which is the difference observed between groups, ignoring any other confounding
variables that might differ between groups. In order to obtain a better estimate of how the treatment or risk factor actually causes a change
in the odds or risk of the outcome, analyses are adjusted for the confounding variables.
Logistic regression is a statistical procedure to estimate the odds of the outcome occurring given one or more predictor variables. This is a
convenient and flexible way to obtain the adjusted odds ratio, but for computational reasons it usually cannot estimate the adjusted relative
risk.
When the regression allows for the effect of the treatment or risk factor of interest to differ for various values of a confounding variable, this
is called interaction, or effect modification.
communicating risks requires absolute as well as relative
measures.8Unfortunately, the risks cannot be obtained at all for
case-control studies. In this case, if a range of plausible baseline
risks can be agreed among authors, perhaps based on published
evidence, this can be used to create a range of plausible relative
risks.
When an odds ratio is adjusted for covariates (typically by
logistic regression), there is no longer a single shared baseline
risk. Instead, different values of the covariates in different
participants mean that their baseline risk differs, and therefore
the relative risk differs too. In such a situation, authors can use
an average baseline risk, or present a range of relative risks
corresponding to an observed or otherwise plausible range of
baseline risks.
A single average risk can be calculated in the context of logistic
regression by finding the mean observed value of each covariate
and entering these values, along with the baseline or control
group indicator, into the regression equation. This will yield a
baseline odds that can then be converted to the baseline risk by
the following equation:
Risk=odds/(1+odds)
Therefore, the odds ratio is converted to an “average relative
risk.”
It may be preferable to provide a range of relative risks rather
than a single average, because the baseline risk is a measure of
risk in the population and could still differ markedly for
individual people. A relatively simple approach to this is to use
the regression model to calculate the baseline odds for every
study participant, rank these odds, and calculate deciles (the
values dividing the study participants into ten equally sized
subgroups in order of their baseline odds). The deciles for
baseline odds are then converted to baseline risks, and hence
the odds ratio is converted to deciles of adjusted relative risks.
However, in more complex models, such as where the odds
ratio for the intervention or risk factor of interest is altered by
one or more covariates (an “interaction” or “effect
modification”), this simple averaging may fail to capture all the
interdependencies in the data. Modern statistical software—for
example, Stata9 and the R package “effects”10—allows for the
calculation of “marginal effects,” which incorporate these
complexities to estimate individuals’ risks, and authors should
be prepared to seek advice on the best way to obtain and
communicate these results.
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Advice for clinical readers of medical
research
Most published research providing an odds ratio as a measure
of effect size should also provide sufficient information for the
baseline risk, and hence the relative risk, to be calculated. If
numbers in each group are given, the crude relative risk can be
calculated directly (box). Even if not all this information is
present, readers can still make some useful attempts at
conversion, which is particularly important for those conducting
meta-analyses and systematic reviews. Readers will need to
decide on a plausible range of baseline risks and thus derive a
plausible range of relative risks. In the case of odds ratios
adjusted for covariates—which is common in contemporary
medical research—readers will not be able to carry out the
approach suggested above for authors (unless they can access
the original data). Therefore, a simple sensitivity analysis is
likely to be helpful, using an upper and lower plausible limit.
This plausible range could be derived from similar, previously
published research, or could use expert opinions.
Example: cluster randomised controlled
trial of hospital based smoking cessation
An illustrative analysis was conducted on Murray and
colleagues’ cluster randomised controlled trial,6 comparing
systematic identification and support to quit smoking with
discretionary support (usual care) in a hospital setting. This
study reported a primary outcome and six secondary outcomes,
with baseline risk (proportions of participants with the outcome
in the usual care arm) ranging from 6% to 29% for different
outcomes (table 2⇓). Here, all the outcomes are positive but it
still makes sense to describe them as risks. The crude odds ratios
and relative risks could be calculated from the reported data,
but estimating adjusted relative risks requires a decision about
a plausible range of baseline risks at different levels of the
confounding factor (in this case, ward discharge rates). Because
this covariate varies between care settings, the Cochrane review
cited by Murray and colleagues was taken as an approximate
guide for the primary outcome, quitting at four weeks. It
included 23 studies with 100 or more participants in the control
arm.11 The baseline risks ranged from 6% to 53% (interquartile
range 9-35), which is about half to double the baseline risk in
Murray and colleagues’ study.6 Follow-up times varied, but this
range appeared plausible; therefore, 9% and 35%were used for
sensitivity analysis.
The plausible crude relative risks ranged from 1.78 to 2.58,
which clearly contained the true known value of 2.28. The
plausible adjusted relative risks ranged from 1.52 to 1.91, which
cannot be verified but still represented a large increase in
smokers’ chances of still having quit at four weeks’ follow-up.
A doctor can clearly advise their patient that “research suggests
this intervention will improve your chances of quitting by
somewhere between 52% and 91%, depending on how soon
you leave hospital.” This advice is more likely to be understood
than the alternative (“will more than double your odds”), or the
incorrect assumption that the odds ratio can be described as an
approximate relative risk and any differences ignored (“will
more than double your chances”). Considering the secondary
outcomes from Murray and colleagues makes this clear: those
with large baseline risks, or large odds ratios, have very large
differences between odds ratios and relative risks.
Conclusion
When communicating risks to patients, it is important to be able
to frame the statistics in a meaningful and easily understood
metric.8 Misinterpretation of the odds ratio can lead to serious
overestimation of the benefits or risks in medical decision
making. It is relatively simple to convert odds to relative risks
given the baseline risk or baseline odds of the outcome.
However, any statistical model which contains a single odds
ratio that is constant for all covariate values does not imply a
constant relative risk, so to communicate relative risks
effectively it is essential to provide a range of relative risks for
different covariate values. These calculations can be conducted
with simple approximations or with modern statistical software,
and authors of medical research should make use of these to
improve communication of their findings. For readers of
published research, there will remain situations where sufficient
information for such a conversion is not given, and here they
should interpret odds ratios with caution; sensitivity analysis
over plausible relative risks is advisable. Conversion is also
potentially helpful in meta-analyses, where different metrics
can prevent studies from being combined.
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Summary points
Odds ratios are not well understood as a measure of effect size, and conversion to relative risks by a simple calculation would improve
understanding of findings
A statistical model with a single fixed odds ratio does not imply a fixed relative risk; in fact, the relative risk differs depending on the
baseline risk of the outcome
When baseline risks have not been published, or the effect is adjusted for other confounding factors, a range of plausible relative risks
is an effective way of representing uncertainty about the effect size in terms of an individual’s risk
In the case of more complex statistical models, modern software can provide estimates of individuals’ risks
Tables
Table 1| Relative risks according to varying values of the odds ratio and baseline risk
Baseline risk
Odds ratio 0.90.80.70.60.50.40.30.20.1
0.7140.5560.4550.3850.3330.2940.2630.2380.2170.2
0.8110.6820.5880.5170.4620.4170.3800.3490.3230.3
0.8700.7690.6900.6250.5710.5260.4880.4550.4260.4
0.9090.8330.7690.7140.6670.6250.5880.5560.5260.5
0.9380.8820.8330.7890.7500.7140.6820.6520.6250.6
0.9590.9210.8860.8540.8240.7950.7690.7450.7220.7
0.9760.9520.9300.9090.8890.8700.8510.8330.8160.8
0.9890.9780.9680.9570.9470.9380.9280.9180.9090.9
1.0001.0001.0001.0001.0001.0001.0001.0001.0001.0
1.0091.0191.0281.0381.0481.0581.0681.0781.0891.1
1.0171.0341.0531.0711.0911.1111.1321.1541.1761.2
1.0241.0481.0741.1021.1301.1611.1931.2261.2621.3
1.0291.0611.0941.1291.1671.2071.2501.2961.3461.4
1.0341.0711.1111.1541.2001.2501.3041.3641.4291.5
1.0391.0811.1271.1761.2311.2901.3561.4291.5091.6
1.0431.0901.1411.1971.2591.3281.4051.4911.5891.7
1.0471.0981.1541.2161.2861.3641.4521.5521.6671.8
1.0501.1051.1661.2341.3101.3971.4961.6101.7431.9
1.0531.1111.1761.2501.3331.4291.5381.6671.8182.0
1.0551.1171.1861.2651.3551.4581.5791.7211.8922.1
1.0581.1221.1961.2791.3751.4861.6181.7741.9642.2
1.0601.1271.2041.2921.3941.5131.6551.8252.0352.3
1.0621.1321.2121.3041.4121.5381.6901.8752.1052.4
1.0641.1361.2201.3161.4291.5631.7241.9232.1742.5
1.0661.1401.2261.3271.4441.5851.7571.9702.2412.6
1.0671.1441.2331.3371.4591.6071.7882.0152.3082.7
1.0691.1481.2391.3461.4741.6281.8182.0592.3732.8
1.0701.1511.2451.3551.4871.6481.8472.1012.4372.9
1.0711.1541.2501.3641.5001.6671.8752.1432.5003.0
1.0731.1571.2551.3721.5121.6851.9022.1832.5623.1
1.0741.1591.2601.3791.5241.7021.9282.2222.6233.2
1.0751.1621.2641.3871.5351.7191.9532.2602.6833.3
1.0761.1641.2691.3931.5451.7351.9772.2972.7423.4
1.0771.1671.2731.4001.5561.7502.0002.3332.8003.5
1.0781.1691.2771.4061.5651.7652.0222.3682.8573.6
1.0791.1711.2801.4121.5741.7792.0442.4032.9133.7
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Table 1 (continued)
Baseline risk
Odds ratio 0.90.80.70.60.50.40.30.20.1
1.0801.1731.2841.4181.5831.7922.0652.4362.9693.8
1.0801.1751.2871.4231.5921.8062.0862.4683.0233.9
1.0811.1761.2901.4291.6001.8182.1052.5003.0774.0
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Table 2| Results from cluster randomised controlled trial by Murray and colleagues6
Adjusted odds
ratio
True crude
relative risk
Crude odds
ratio
No of participants with outcome/Total No of participants (%)
Outcome
Intervention arm outcome (post
intervention risk)
Usual care arm outcome
(baseline risk)
2.102.283.0698/260 (38%)37/224 (17%)Quit at 4 weeks (primary outcome)
5.712.395.64185/264 (70%)17/58 (29%)Accepted behavioural support
1.951.973.29151/262 (58%)67/229 (29%)Abstained at discharge
3.951.802.57128/262 (49%)62/229 (27%)Discharged with pharmacotherapy
21.809.6820.28144/262 (55%)13/229 (6%)Referred to stop smoking service
4.223.334.3580/262 (31%)21/229 (9%)Received support from stop
smoking service
1.532.172.4447/250 (19%)19/219 (9%)Quit between discharge and 6
months later
Trial compared effect of systematic identification and support to quit smoking with discretionary support (usual care) in a hospital setting.
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Figure
Relation between the odds ratio, relative risk, and baseline risk (p0)
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